Skip to main content

Novartis Australia Pty Ltd

Regulatory activities for this sponsor.

Sponsor content

4 result(s) found, displaying 1 to 4
  • AusPAR: Erenumab

    Australian Public Assessment Report for Erenumab
  • AusPAR: Omalizumab (rch)

    Australian Public Assessment Report for Omalizumab (rch)
  • AusPAR: Ruxolitinib

    Australian Public Assessment Report for Ruxolitinib
  • AusPAR: Zoledronic acid

    Australian Public Assessment Report for Zoledronic acid

Help us improve the Therapeutic Goods Administration site